Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

NAFLD-NASH: An Under-Recognized Epidemic.

Current vascular pharmacology - 1 Jan 2018

Jennings Joseph, Faselis Charles, Yao Michael D

Abstract excerpt

First described in 1980, nonalcoholic fatty liver disease (NAFLD) has become more common although the exact incidence and prevalence is unknown. While the exact prevalence varies from region to region, the overall trend shows an increased number of patients with NAFLD. Risk factors for the development of NAFLD includes advanced age, male gender, obesity, and having elements of the metabolic syndrome. There is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coronary Artery Disease
Share to Epidemics
Share to Global Health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hispanic or Latino

Share to Incidence

Share to Lipase

Share to Metabolic Syndrome

Share to Non-alcoholic Fatty Liver Disease

Source

Identifiers

PMID: 28676024
DOI: 10.2174/1570161115666170622074007

Genes

PNPLA3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

NAFLD-NASH: An Under-Recognized Epidemic.PMID 28676024Read ↗

Epidemiology of nonalcoholic fatty liver disease in non-obese populations: Meta-analytic assessment of its prevalence, genetic, metabolic, and histological profiles.Semantic proximity Read ↗

Nonalcoholic fatty liver disease.Semantic proximity Read ↗

Non-alcoholic fatty liver disease: what the clinician needs to know.Semantic proximity Read ↗

Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies.Semantic proximity Read ↗

NAFLD in Asia--as common and important as in the West.Semantic proximity Read ↗

Non-alcoholic fatty liver disease.Semantic proximity Read ↗

Non-alcoholic Fatty Liver Disease (NAFLD) Management in the CommunitySemantic proximity Read ↗

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.Semantic proximity Read ↗

Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.Semantic proximity Read ↗

Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.Semantic proximity Read ↗

Geographical similarity and differences in the burden and genetic predisposition of NAFLD.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.